Skip to main content
. Author manuscript; available in PMC: 2021 Mar 5.
Published in final edited form as: J Alzheimers Dis. 2020;75(3):717–728. doi: 10.3233/JAD-190967

Table 1.

Descriptive statistics of the 52 variables in the sample.

Demographics N M SD Min Max
 Age 9,979 67.01 9.18 50 98
 Gender (female) 9,979 59.8%
 Education (in years) 9,963 13.27 2.61 0 17
 Race (African American) 9,976 9.3%
 Race (Other) 9,976 3.5%
 Ethnicity (Hispanic) 9,979 6.2%
 Income (in 1,000 USD) 9,966 66.88 61.97 0 300
 Wealth (in 1,000 USD) 9,966 554.19 816.91 −769 5,060
 Marital status (married) 9,978 67.3%
 Work 9,809 37.6%
 Type home (assisted) 9,811 0.6%
Psychosocial N M SD Min Max
 Conscientiousness 9,895 3.41 0.45 1 4
 Openness 9,877 2.99 0.53 1 4
 Extraversion 9,908 3.26 0.53 1 4
 Agreeableness 9,906 3.55 0.45 1 4
 Emotional distress (z) 9,978 −0.01 0.68 −1.31 3.39
 Life satisfaction (z) 9,857 0.06 0.98 −2.82 1.67
 Positive affect (z) 9,877 0.08 0.95 −3.70 2.04
 Purpose in life 9,821 4.70 0.90 1 6
 Optimism 9,843 4.57 1.12 1 6
 Social contact 7,213 3.72 0.76 1 6
Health N M SD Min Max
 Subjective health 9,972 3.35 1.02 1 5
 Childhood health 6,765 4.23 0.94 1 5
 Hearing 9,975 3.43 1.06 1 5
 Hear aid 9,302 1.8%
 Sleep medication 9,975 19.8%
 Childhood traumas 9,901 0.34 0.60 0 3
 Lifetime traumas 9,911 1.23 1.18 0 7
 BMI 9,807 28.97 5.65 11.18 83.82
 Highest BMI ever 9,908 30.82 6.55 11.33 49.71
 BMI slope 9,979 0.00 0.99 −3.59 3.58
 Waist circumference 8,781 39.34 5.60 25.00 55.25
 Hypertension 9,960 55.8%
 Diabetes 9,961 18.0%
 Heart disease 9,965 22.9%
 Stroke 9,966 4.9%
 Cancer 9,976 14.8%%
 Alcohol 9,965 56.3%
 Mild activity 9,963 93.7%
 Moderate activity 9,962 83.7%
 Vigorous activity 9,960 42.9%
 Total activity 9,966 96.6%
 Smoking ever 9,978 52.6%
 Functional limitations 8,920 2.14 2.43 0 10
 Grip strength 7,802 32.12 10.82 0.50 60.50
Biomarker/Polygenic N M SD Min Max
 Cholesterol 7,802 203.24 41.69 89.04 405.41
 High Density Lipoprotein 6,748 55.55 16.30 12.11 139.52
 Cystatin C 7,820 0.00 0.13 −0.64 0.98
 C Reactive Protein 7,891 0.30 0.51 −1.70 2.34
 Hemoglobin A1C 8,119 5.81 0.90 4.07 14.79
 Polygenic score APOE without ε4 7,082 −0.03 1.00 −3.95 4.08
 Polygenic score APOE with ε4 7,082 −0.03 1.00 −3.95 4.07
Cognitive Status N M SD Min Max
 Impairment 3,119 (31.3%)
 Dementia 622 (6.2%)
 Time-to-detection impairment 9,979 6.85 2.76 2 10
 Time-to-detection dementia 9,979 7.67 2.33 2 10
 Age at onset impairment 9,979 73.86 8.70 52 101
 Age at onset dementia 9,979 74.68 8.79 52 101

Note. N = number of participants; M = mean; SD = standard deviation. Data of 52 predictors were obtained in 2006 or 2008, respectively, except polygenic scores, which were obtained in 2013. Smoking refers to whether participants have ever smoked from 1992 to 2008. We included three variables of BMI: BMI at baseline, highest BMI ever and BMI slope. Given that there was no measure for midlife obesity in the data, highest BMI ever and BMI slope seemed the best possible alternatives. BMI slope was calculated using information from the earliest available measurement occasion in HRS - e.g., 1992 - until 2 years before year of detection of cognitive impairment/dementia or the last year of cognitive testing for unimpaired individuals. Emotional distress is an averaged factor consisting of standardized negative emotion variables (i.e., neuroticism, hostility, anxiety, negative affect, hopelessness, pessimism, depression, loneliness and perceived constraints). The items of life satisfaction were rated on a scale from 1–6 in 2006 and from 1–7 in 2008. Scores were thus standardized before combining them. For positive affect, participants rated 6 (in 2006) and 12 (in 2008) items. Scores were thus standardized before combining them. Time-to-detection (in years) refers to years from baseline to year in which onset of impairment/dementia was detected. The assessment of all variables is described in the supplementary material.